These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36532547)

  • 21. Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.
    Hopkins JJ; Reif R; Bigam D; Baracos VE; Eurich DT; Sawyer MM
    World J Surg; 2019 Oct; 43(10):2518-2526. PubMed ID: 31222643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
    Ebadi M; Martin L; Ghosh S; Field CJ; Lehner R; Baracos VE; Mazurak VC
    Br J Cancer; 2017 Jun; 117(1):148-155. PubMed ID: 28588319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    Int J Colorectal Dis; 2018 Oct; 33(10):1419-1427. PubMed ID: 29987364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical performance has a strong association with poor surgical outcome in older patients with colorectal cancer.
    Souwer ET; Moos SI; van Rooden CJ; Bijlsma AY; Bastiaannet E; Steup WH; Dekker JWT; Fiocco M; van den Bos F; Portielje JE
    Eur J Surg Oncol; 2020 Mar; 46(3):462-469. PubMed ID: 31899045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients.
    Sevgilioglu ZE; Evrimler S; Iscan G; Kayikcioglu E; Sengul SS; Cetin B
    Acta Radiol; 2023 Nov; 64(11):2849-2857. PubMed ID: 37661639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival.
    Huang X; Ma J; Li L; Zhu XD
    Cancer Med; 2019 Nov; 8(15):6604-6613. PubMed ID: 31517443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.
    Giani A; Famularo S; Fogliati A; Riva L; Tamini N; Ippolito D; Nespoli L; Braga M; Gianotti L
    World J Surg Oncol; 2022 Feb; 20(1):51. PubMed ID: 35216606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
    Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Body Composition on Prognosis and Dose-Limiting Toxicities on Metastatic Colorectal Cancer.
    da Silva Dias D; Machado M; Trabulo C; Gosálbez B; Ravasco P
    Front Nutr; 2021; 8():671547. PubMed ID: 35155507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low skeletal muscle mass and high visceral adiposity are associated with recurrence of acute cholecystitis after conservative management: A propensity score-matched cohort study.
    Koya Y; Shibata M; Maruno Y; Sakamoto Y; Oe S; Miyagawa K; Honma Y; Harada M
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):64-70. PubMed ID: 37516589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Perioperative Skeletal Muscle Index Change With Outcome in Colorectal Cancer Patients.
    Li Z; Yan G; Liu M; Li Y; Liu L; You R; Cheng X; Zhang C; Li Q; Jiang Z; Ruan J; Ding Y; Li W; You D; Liu Z
    J Cachexia Sarcopenia Muscle; 2024 Oct; ():. PubMed ID: 39360467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.
    Abe H; Takei K; Uematsu T; Tokura Y; Suzuki I; Sakamoto K; Nishihara D; Yamaguchi Y; Mizuno T; Nukui A; Kobayashi M; Kamai T
    Int J Clin Oncol; 2018 Apr; 23(2):338-346. PubMed ID: 29098519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed Tomography-Determined Sarcopenia Is a Useful Imaging Biomarker for Predicting Postoperative Outcomes in Elderly Colorectal Cancer Patients.
    Xie H; Gong Y; Kuang J; Yan L; Ruan G; Tang S; Gao F; Gan J
    Cancer Res Treat; 2020 Jul; 52(3):957-972. PubMed ID: 32311863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between postoperative muscle wasting and survival in older patients undergoing surgery for non-metastatic colorectal cancer.
    Argillander TE; Spek D; van der Zaag-Loonen HJ; van Raamt AF; van Duijvendijk P; van Munster BC
    J Geriatr Oncol; 2021 Sep; 12(7):1052-1058. PubMed ID: 33858804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
    Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.
    Gallois C; Bourillon C; Auclin E; Artru P; Lièvre A; Lecomte T; Locher C; Marthey L; Faroux R; Pernot S; Barret M; Taieb J
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101603. PubMed ID: 33662782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.
    Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.